Synthetic absorbable hemostatic agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 17, 1984
Grant Date -
N/A
app pub date -
Nov 16, 1982
filing date -
Nov 16, 1982
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A synthetic absorbable hemostatic agent for use in the control of osseous hemorrhage, comprising a copolymer of lactide and glycolide containing from about 30% to 70% lactide on a molar basis, and having a molecular weight such that it possesses a putty-like consistency at room temperature. The preferred agent has a lactide/glycolide molar ratio of 65:35 and a molecular weight of between 2000 and 2500 Dalton. The agent may also be mixed with a biocompatible base.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully